| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/27/2001 | CN1301254A Nonnucleoside inhibitors of reverse transcriptase for the treatment of hiv-infection |
| 06/27/2001 | CN1301253A Carboxy substituted carboxamide derivatives as tachykinin receptor antagonists |
| 06/27/2001 | CN1301180A Recombinant i(mycoplasma hyopneumoniae) vaccine |
| 06/27/2001 | CN1301175A Humanized antibodies that recognize verotoxin II and cell line producing same |
| 06/27/2001 | CN1301173A Pharmaceutical composition containing a cysteine protease inhibitor for prophylaxis and therapy of brain tissue impairment |
| 06/27/2001 | CN1301166A Steroidal saponins for treating alzheimer's disease |
| 06/27/2001 | CN1301165A Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor |
| 06/27/2001 | CN1301162A Method for combating obesity |
| 06/27/2001 | CN1301161A Serotonergic 5HT receptor compounds for treating ocular and CNS disorders |
| 06/27/2001 | CN1301160A Therapeutic combinations of (selective) estrogen receptor modulators (SERM) and growth hormone secretagogues (GHS) for treating musculoskeletal frailty |
| 06/27/2001 | CN1301159A Cabergoline and pramipexole: new uses and combinations |
| 06/27/2001 | CN1301156A Treatment of T-Helper cell tyre 2 mediated immune diseases with retinoid antagonists |
| 06/27/2001 | CN1301133A Food products having enhanced cocoa polyphenol content and processes for producing same |
| 06/27/2001 | CN1300593A Medical application of pseudo-paraquilon F11 |
| 06/27/2001 | CN1067683C Substituted morpholine derivatives and their use as therapeutic agents |
| 06/27/2001 | CN1067678C Alkyl heterocyclic compound and preparation method thereof, and medicinal composition containing that kind of compound |
| 06/27/2001 | CN1067581C Americum ginseng tea and its preparation process |
| 06/27/2001 | CN1067578C Chinese herb medicine allicin health-care liquid |
| 06/27/2001 | CN1067575C Saussurea involucrate and safflower wine and its prepn. method |
| 06/27/2001 | CN1067553C Oyster extract and method for preparing its prepn. |
| 06/27/2001 | CN1067550C Calcium receptor active molecules |
| 06/26/2001 | US6253104 Method of preparing pharmaceutical Moxa extract and apparatus for electrical moxibustion using the same extract |
| 06/26/2001 | US6252116 Intermediates useful in a process for synthesizing COX-2 inhibitors |
| 06/26/2001 | US6252086 4-alkenyl-and 4-alkynyloxindoles |
| 06/26/2001 | US6252070 Reacting aryl bromide with butyllithium and zinc bromide to give aryl zinc bromide; reacting with corresponding benzothiazine compound |
| 06/26/2001 | US6252051 ErbB4 receptor-specific neuregulin related ligand antibodies and uses therefor |
| 06/26/2001 | US6251950 Administering to the patient an aliphatic-propargylamine or salt for the treatment of acute and chronic diseases in which cell death occurs by apoptosis or for the treatment of premature degeneration of cells in mammals |
| 06/26/2001 | US6251948 Trisubstituted guanidine useful for treating diseases of the nervous system in which the pathophysiology of the disease involves excessive excitation of nerve cells by agonists of glutamate/n-methyl-d-aspartate receptor |
| 06/26/2001 | US6251942 Compositions and methods for alleviating impaired mental function, memory loss and reducing recovery time in anaesthetized mammals |
| 06/26/2001 | US6251940 Administering to the mammal suffering from a diseases responsive to inhibit monocyte and/or macrophase and/or lymphocyte activation and of lymphocyte proliferation an amide derivative |
| 06/26/2001 | US6251935 Administration of a racemic alpha-lipoic acid, enantiomers and pharmaceutically acceptable salts, amides, esters or thioester, in reduced or oxidized form as antimigraine agent |
| 06/26/2001 | US6251926 Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity |
| 06/26/2001 | US6251925 An agonists for human beta-3 adrenoceptor |
| 06/26/2001 | US6251924 Pharmaceutical composition |
| 06/26/2001 | US6251923 Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and process for their preparation |
| 06/26/2001 | US6251917 Benzamidoaldehydes and their use as cysteine protease inhibitors |
| 06/26/2001 | US6251914 Treating cytokine mediated diseases |
| 06/26/2001 | US6251913 Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor |
| 06/26/2001 | US6251911 Pyrimidine derivatives and processes for the preparation thereof |
| 06/26/2001 | US6251909 Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 06/26/2001 | US6251908 Piperazine derivatives |
| 06/26/2001 | US6251904 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction |
| 06/26/2001 | US6251903 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonist |
| 06/26/2001 | US6251902 Dipeptide derivatives as growth hormone secretagogues |
| 06/26/2001 | US6251894 1-(1,2-disubstituted piperidinyl)-4 (fused imidazole)-piperidine derivatives |
| 06/26/2001 | US6251893 Bicyclic piperidine and piperazine compounds having 5-HT6 receptor affinity |
| 06/26/2001 | US6251892 Neurotrophic low molecular weight small molecule n-oxides of heterocyclic esters, amides, thioesters and ketones; inhibitors of enzyme activity associated with immunophilin proteins, particularly peptidyl-prolyl isomerase or rotamase |
| 06/26/2001 | US6251887 17β-aryl(arylmethyl)oxy(thio)alkyl-androstane derivatives |
| 06/26/2001 | US6251877 Topically administering to individual composition comprising purified beta-1,6-branched-beta-1,3-glucan from schizophyllum commune in amount effective to cause proliferation of skin cells |
| 06/26/2001 | US6251867 Antiangiogenic peptides and methods for inhibiting angiogenesis |
| 06/26/2001 | US6251671 Culturing mammalian spermatogonial stem cells with bone morphogenetic protein 8 to cause proliferation of the stem cells and survival of spermatocytes |
| 06/26/2001 | US6251669 Mammalian, non-tumor derived cells which divide, express neuron-specific markers, and give rise to progeny which differentiate into neuronal cells; for transplantation in treatment of alzheimer's/parkinson's diseases |
| 06/26/2001 | US6251652 Amino acid sequence from staphylococcus cystathionine gamma-lyase gene; drug screening; bactericides; bacteriostats; vaccines; antibodies |
| 06/26/2001 | US6251628 Isolated nucleic acid molecules encoding Smad7 |
| 06/26/2001 | US6251585 Assay and reagents for identifying anti-proliferative agents |
| 06/26/2001 | US6251442 Feed composition for broilers and method for breeding broilers |
| 06/26/2001 | US6251407 And adjuvant selected from manganese gluconate, calcium gluconate, zinc gluconate, calcium fructoheptonate, zinc glucoheptonate, or calcium glycerophosphate and an oily phase ester of ethoxylated fatty acids; immunostimulatory |
| 06/26/2001 | US6251380 Extraction of plants with methanol, dichloromethane, ethyl acetate, mixing and drying then dilution |
| 06/26/2001 | CA2245461C Detection of conditions or diseases associated with an altered level of telomerase activity |
| 06/24/2001 | CA2329516A1 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists |
| 06/22/2001 | CA2329678A1 Ep4 receptor selective agonists in the treatment of osteoporosis |
| 06/21/2001 | WO2001044514A2 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements |
| 06/21/2001 | WO2001044512A2 Method of identifying ligands for the peroxisome proliferator activated receptor gamma using differential gene expression |
| 06/21/2001 | WO2001044473A2 Polypeptides and nucleic acids encoding same |
| 06/21/2001 | WO2001044465A2 Therapeutically useful synthetic oligonucleotides |
| 06/21/2001 | WO2001044455A2 Antisense oligonucleotides for the inhibition of expression of type i procollagen |
| 06/21/2001 | WO2001044448A2 Human oxidoreductase proteins |
| 06/21/2001 | WO2001044445A2 Human lyases and associated proteins |
| 06/21/2001 | WO2001044294A2 Compositions and methods for inhibiting endothelial cell proliferation |
| 06/21/2001 | WO2001044284A2 Chimeric natriuretic peptides |
| 06/21/2001 | WO2001044282A2 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 06/21/2001 | WO2001044264A2 Novel stromelysin inhibitors |
| 06/21/2001 | WO2001044254A1 Cyclopenteneone derivatives |
| 06/21/2001 | WO2001044246A1 Bicyclic inhibitors of glycogen synthase kinase 3 |
| 06/21/2001 | WO2001044245A1 Saccharin derivatives as orally active elastase inhibitors |
| 06/21/2001 | WO2001044244A1 Pyrazolo-pyridine derivatives as ligands for gaba receptors |
| 06/21/2001 | WO2001044243A2 Novel heteroaryl-diazabicycloalkanes |
| 06/21/2001 | WO2001044242A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]carboxamide inhibitors of cyclin dependent kinases |
| 06/21/2001 | WO2001044241A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| 06/21/2001 | WO2001044239A2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 06/21/2001 | WO2001044234A1 Substituted bisindolylmaleimides for the inhibition of cell proliferation |
| 06/21/2001 | WO2001044229A1 Chemokine receptor binding heterocyclic compounds |
| 06/21/2001 | WO2001044223A1 Inhibitors of interleukin 5 gene expression |
| 06/21/2001 | WO2001044217A1 Aminothiazole inhibitors of cyclin dependent kinases |
| 06/21/2001 | WO2001044216A1 Trans olefinic glucokinase activators |
| 06/21/2001 | WO2001044207A2 Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them |
| 06/21/2001 | WO2001044206A1 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 06/21/2001 | WO2001044203A1 N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses |
| 06/21/2001 | WO2001044193A1 1,3,4-substituted piperidine analogs and uses thereof in treating addictions |
| 06/21/2001 | WO2001044177A2 Somatostatin analogs, radiolabelled derivatives thereof and their use |
| 06/21/2001 | WO2001044170A1 Adamantane derivatives |
| 06/21/2001 | WO2001043761A2 Methods for treating and preventing damage to mucosal tissue |
| 06/21/2001 | WO2001043758A1 Nutritional composition, methods of producing said composition and methods of using said composition |
| 06/21/2001 | WO2001043753A2 Combination of ginseng and ginkgo to improve cognitive skills |
| 06/21/2001 | WO2001043751A1 Novel helicobacter pylori-binding substances and use thereof |
| 06/21/2001 | WO2001043747A1 Matrix tablet for prolonged release of trimetazidine after oral administration |
| 06/21/2001 | WO2001043745A1 The use of scopolamine salts |
| 06/21/2001 | WO2001043743A1 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
| 06/21/2001 | WO2001043731A2 Inhibitors of adenosine kinase for the treatment of optic nerve and retinal damage |
| 06/21/2001 | WO2001043711A1 Cosmetic skin conditioning compositions containing red yeast rice extract |